According to REGENXBIO's latest financial reports the company has S$0.35 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $S$0.35 B | -14.28% |
2023-12-31 | $S$0.41 B | -40.5% |
2022-12-31 | $S$0.69 B | -33.03% |
2021-12-31 | $S$1.03 B | 106.76% |
2020-12-31 | $S$0.49 B | -17.66% |
2019-12-31 | $S$0.60 B | -12.69% |
2018-12-31 | $S$0.69 B | 183.97% |
2017-12-31 | $S$0.24 B | 4.58% |
2016-12-31 | $S$0.23 B | -23.67% |
2015-12-31 | $S$0.30 B | -4173.34% |
2014-12-31 | $-S$7.53 Million | 177.3% |
2013-12-31 | $-S$2.72 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | S$0.28 B | -19.86% | ๐บ๐ธ USA |